După 25 de ani, terapia hormonală în menopauză este reevaluată: ce spun noile date

Recent studies suggest a reevaluation of menopausal hormone therapy, previously avoided due to health risks. New data indicates that when initiated within ten years of menopause, the therapy can significantly improve quality of life without substantial cardiovascular risks. The FDA has lifted strict warnings, acknowledging that risks vary based on individual factors. While hormone therapy is not suitable for everyone, it can greatly benefit certain patients when prescribed after thorough medical evaluation.